GSK Initiates Process For Withdrawal Of US Marketing Authori

LONDON (dpa-AFX) - GSK plc (GSK, GSK.L) said that it has initiated the process for withdrawal of the US marketing authorization for blood cancer drug Blenrep following the request of the US Food

Related Keywords

London , City Of , United Kingdom , , Drug Administration , More Such Health News , Einitiates , Process , Withdrawal , Marketing , Authorization , Flood , Dancer , Drug , Blenrep ,